HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts.

AbstractRATIONALE:
Smooth muscle cells (SMCs) are a key component of tissue-engineered vessels. However, the sources by which they can be isolated are limited.
OBJECTIVE:
We hypothesized that a large number of SMCs could be obtained by direct reprogramming of fibroblasts, that is, direct differentiation of specific cell lineages before the cells reaching the pluripotent state.
METHODS AND RESULTS:
We designed a combined protocol of reprogramming and differentiation of human neonatal lung fibroblasts. Four reprogramming factors (OCT4, SOX2, KLF4, and cMYC) were overexpressed in fibroblasts under reprogramming conditions for 4 days with cells defined as partially-induced pluripotent stem (PiPS) cells. PiPS cells did not form tumors in vivo after subcutaneous transplantation in severe combined immunodeficiency mice and differentiated into SMCs when seeded on collagen IV and maintained in differentiation media. PiPS-SMCs expressed a panel of SMC markers at mRNA and protein levels. Furthermore, the gene dickkopf 3 was found to be involved in the mechanism of PiPS-SMC differentiation. It was revealed that dickkopf 3 transcriptionally regulated SM22 by potentiation of Wnt signaling and interaction with Kremen1. Finally, PiPS-SMCs repopulated decellularized vessel grafts and ultimately gave rise to functional tissue-engineered vessels when combined with previously established PiPS-endothelial cells, leading to increased survival of severe combined immunodeficiency mice after transplantation of the vessel as a vascular graft.
CONCLUSIONS:
We developed a protocol to generate SMCs from PiPS cells through a dickkopf 3 signaling pathway, useful for generating tissue-engineered vessels. These findings provide a new insight into the mechanisms of SMC differentiation with vast therapeutic potential.
AuthorsEirini Karamariti, Andriana Margariti, Bernhard Winkler, Xiaocong Wang, Xuechong Hong, Dilair Baban, Jiannis Ragoussis, Yi Huang, Jing-Dong J Han, Mei Mei Wong, Can M Sag, Ajay M Shah, Yanhua Hu, Qingbo Xu
JournalCirculation research (Circ Res) Vol. 112 Issue 11 Pg. 1433-43 (May 24 2013) ISSN: 1524-4571 [Electronic] United States
PMID23529184 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • CTNNB1 protein, human
  • Chemokines
  • DKK3 protein, human
  • Intercellular Signaling Peptides and Proteins
  • KLF4 protein, human
  • KREMEN1 protein, human
  • Klf4 protein, mouse
  • Kruppel-Like Factor 4
  • Membrane Proteins
  • Microfilament Proteins
  • Muscle Proteins
  • beta Catenin
  • transgelin
Topics
  • Adaptor Proteins, Signal Transducing
  • Blood Vessel Prosthesis
  • Cell Differentiation (physiology)
  • Cell Nucleus (metabolism)
  • Cell Separation (methods)
  • Chemokines
  • Fetus (cytology)
  • Fibroblasts (cytology, metabolism)
  • Humans
  • Intercellular Signaling Peptides and Proteins (metabolism)
  • Kruppel-Like Factor 4
  • Lung (cytology)
  • Membrane Proteins (metabolism)
  • Microfilament Proteins (genetics, metabolism)
  • Muscle Proteins (genetics, metabolism)
  • Myocytes, Smooth Muscle (cytology, metabolism)
  • Pluripotent Stem Cells (cytology)
  • Transcriptional Activation (physiology)
  • Wnt Signaling Pathway (physiology)
  • beta Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: